Position in AZN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$21,210,089
+$3,044,353 QoQ
Shares Held
1,549,304
+1582.0% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#227
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 5%
Shared 1%
None 95%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $2,818,388,817 across 16 Drug Manufacturers - General names. AZN ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,206,575 | $764,096,470 | |
| 2 | JNJ |
Johnson & Johnson
|
6,060,922 | $672,880,917 | |
| 3 | ABBV |
AbbVie Inc.
|
19,562,230 | $557,310,914 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,683,612 | $322,525,314 | |
| 5 | AMGN |
Amgen Inc
|
1,041,051 | $187,400,837 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,478,397 | $73,717,881 | |
| 7 | NVS |
Novartis AG
|
447,726 | $70,167,618 | |
| 8 | PFE |
Pfizer Inc
|
2,945,297 | $67,458,829 |
All Filings in AZN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,431,965 | 1,445,000 | Principal | Sole | 2026-08-17 | |
| 2026-06-30 | $19,778,124 | 104,304 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $18,165,736 | 92,109 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||